share_log

Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $12 Price Target

Benzinga ·  Sep 10 21:54  · Ratings

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment